Kingsview Wealth Management »

SPDR S&P Pharmaceuticals shares owned by Kingsview Wealth Management

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Kingsview Wealth Management from 13F filings

Historical chart of Kingsview Wealth Management investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Kingsview Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Kingsview Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 28k 41.62
2023-09-30 $697k 18k 39.75
2023-03-31 $311k 7.6k 41.01

More positions owned by Kingsview Wealth Management

Apple (AAPL)
Northern Lts Fd Tr Iv Monarch Procap (MPRO)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Northern Lts Fd Tr Iv Monarch Ambasadr (MAMB)
Northern Lts Fd Tr Iv Monarch Blue Ch (MBCC)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Technology (XLK)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Innovator Etfs Tr Defined Wlt Shld (BALT)
Innovator Etfs Tr Laderd Alctn Pwr (BUFF)

View all positions for Kingsview Wealth Management

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
First Citizens Bank & Trust
Bnp Paribas Arbitrage, Snc
Envestnet Portfolio Solutions
Wharton Business Group
UBS Group
MAI Wealth Advisors
Kingsview Wealth Management
Pnc Financial Services
Royal Bank of Canada
Citadel Advisors
AE Wealth Management

View all funds holding SPDR S&P Pharmaceuticals